News
Top local executive of Allergan Aesthetics Carrie Strom announces her departure from the AbbVie-owned company.
In today's trading context, the average open interest for options of AbbVie stands at 3048.78, with a total volume reaching 10,547.00. The accompanying chart delineates the progression of both ...
Imagine standing on a vast, dark plain. Without light, you cannot see dips and rolls in the grass or make out hills and valleys. Even if there’s a city off in the distance to your right, it does ...
AbbVie has filed a lawsuit against Genmab, accusing the Danish drugmaker of being “intentionally and willfully blind” to the theft of trade secrets. Genmab has vowed to “vigorously defend ...
Ross, M.D., Ph.D., vice president, early oncology research and development, AbbVie. "By harnessing the latest scientific breakthroughs in translational research, we are advancing novel therapeutic ...
April 3 (Reuters) - AbbVie (ABBV.N), opens new tab on Thursday cut its 2025 adjusted profit forecast as the drugmaker expects to incur $248 million in acquisition expenses related to milestone ...
AbbVie (ABBV) closed the most recent trading day at $209.17, moving -0.4% from the previous trading session. The stock trailed the S&P 500, which registered a daily gain of 1.77%. At the same time ...
AbbVie (NYSE:ABBV) shares snap seven straight sessions of losses, as the stock ended 0.71% higher at $202.72 on Thursday. The biopharmaceutical company lost nearly 6% in the preceding seven ...
So, you want to invest in AbbVie (ABBV-0.28%) because it's a promising dividend-paying stock, and you also want to receive $1,000 per year in dividend income from it. How many shares should you buy?
This organisational change comes less than five years after Happiest Minds founder Ashok Soota expressed hesitance in adopting a CEO structure. Instead, the company had an executive board ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results